ProAxsis Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
ProAxsis General Information
Description
Developer of a range of medical diagnostics products designed to capture, detect, and measure the active protease biomarkers of diseases. The company's technology provides a visual readout of active proteases in complex biological samples with a high level of specificity and selectivity and has the potential to be incorporated into point-of-care tests, companion diagnostics, and activity-based immunoassays, enabling healthcare professionals to get a visual readout of the tests within the clinic or at home.
Contact Information
Website
www.proaxsis.comCorporate Office
- Building 75 Randox Science Park, 30
- Randalstown Road, Antrim, Northern Ireland
- Belfast BT41 4FL
- Northern Ireland, United Kingdom
Corporate Office
- Building 75 Randox Science Park, 30
- Randalstown Road, Antrim, Northern Ireland
- Belfast BT41 4FL
- Northern Ireland, United Kingdom
ProAxsis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 12. Later Stage VC | 07-Jul-2025 | Completed | Generating Revenue | |||
| 11. Grant | 01-Aug-2022 | Completed | Generating Revenue | |||
| 10. Grant | 01-Oct-2021 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 01-Oct-2020 | Completed | Generating Revenue | |||
| 8. Grant | 01-Jun-2020 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 24-Jul-2017 | Completed | Generating Revenue | |||
| 6. Buyout/LBO | 31-Dec-2016 | Completed | Startup | |||
| 5. Accelerator/Incubator | 01-Jan-2016 | $49.4K | $297K | Completed | Startup | |
| 4. Grant | 08-Jun-2014 | $68.3K | $248K | Completed | Startup |
ProAxsis Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| Ordinary Shares | ||||||||
| D Ordinary | 2,353 | $1.358866 | $28.88 | $28.88 | 1x | $28.88 | 16.62% | |
| C Ordinary | 5,647 | $1.358866 | $24.06 | $24.06 | 1x | $24.06 | 39.89% |
ProAxsis Patents
ProAxsis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20120156691-A1 | Compound | Active | 26-Aug-2009 | ||
| US-9340820-B2 | Compounds and methods for protease detection | Active | 26-Aug-2009 |
ProAxsis Signals
ProAxsis Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innovate UK | Government | |||
| EMV Capital | Venture Capital | Majority | ||
| Queen's University Belfast | University | Minority |
ProAxsis FAQs
-
When was ProAxsis founded?
ProAxsis was founded in 2013.
-
Where is ProAxsis headquartered?
ProAxsis is headquartered in Belfast, United Kingdom.
-
What is the size of ProAxsis?
ProAxsis has 11 total employees.
-
What industry is ProAxsis in?
ProAxsis’s primary industry is Diagnostic Equipment.
-
Is ProAxsis a private or public company?
ProAxsis is a Private company.
-
What is ProAxsis’s current revenue?
The current revenue for ProAxsis is .
-
How much funding has ProAxsis raised over time?
ProAxsis has raised $2.52M.
-
Who are ProAxsis’s investors?
Innovate UK, EMV Capital, and Queen's University Belfast have invested in ProAxsis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process